NASDAQ:ACHC • US00404A1097
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACADIA HEALTHCARE CO INC (ACHC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-26 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2026-02-26 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-26 | UBS | Maintains | Buy -> Buy |
| 2026-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-23 | Guggenheim | Maintains | Buy -> Buy |
| 2026-01-22 | Jefferies | Downgrade | Buy -> Hold |
| 2026-01-16 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-18 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-12-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-03 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-12-03 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-12-03 | UBS | Maintains | Buy -> Buy |
| 2025-12-03 | Deutsche Bank | Maintains | Buy -> Buy |
| 2025-12-03 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-12-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-03 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-11-18 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-11-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-07 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-11-07 | UBS | Maintains | Buy -> Buy |
| 2025-11-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.929B 12.19% | 3.154B 7.69% | 3.313B 5.04% | 3.486B 5.23% | 3.694B 5.97% | 3.9B 5.58% | 4.28B 9.74% | N/A | N/A | |
| EBITDA YoY % growth | 638.945M 13.29% | 671.871M 5.15% | 577.214M -14.09% | 608.56M 5.43% | 649.59M 6.74% | 683.86M 5.28% | 981.24M 43.49% | 1.039B 5.89% | 1.039B | |
| EBIT YoY % growth | 506.596M 13.54% | 522.276M 3.10% | 387.965M -25.72% | 406.66M 4.82% | 424.99M 4.51% | N/A | N/A | N/A | N/A | |
| Operating Margin | 17.30% | 16.56% | 11.71% | 11.67% | 11.50% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 3.43 -10.91% | 3.30 -3.79% | 2.02 -38.79% | 1.50 -25.62% | 1.73 15.38% | 1.92 10.67% | 1.87 -2.71% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.27 -32.19% | 0.50 -39.67% | 0.59 -17.86% | 0.41 489.82% | 0.43 59.37% | 0.83 65.44% | 0.71 20.18% | 0.55 32.32% |
| Revenue Q2Q % growth | 839.38M 8.94% | 883.57M 1.65% | 899.25M 5.60% | 855.97M 4.20% | 888.82M 5.89% | 970.27M 9.81% | 947.95M 5.42% | 915.66M 6.97% |
| EBITDA Q2Q % growth | 136.6M 8.82% | 168.99M -29.09% | 174.36M -33.71% | 151.54M -36.03% | 152.29M 11.49% | 208.77M 23.54% | 192.34M 10.31% | 171.78M 13.36% |
| EBIT Q2Q % growth | 77.474M -1.30% | 109.03M -23.38% | 119.74M 0.18% | 99.784M 109.44% | 98.573M 27.23% | 146.52M 34.39% | 134.4M 12.24% | 117.4M 17.65% |
All data in USD
20 analysts have analysed ACHC and the average price target is 19.53 USD. This implies a price decrease of -14.1% is expected in the next year compared to the current price of 22.73.
ACADIA HEALTHCARE CO INC (ACHC) will report earnings on 2026-05-11, after the market close.
The consensus EPS estimate for the next earnings of ACADIA HEALTHCARE CO INC (ACHC) is 0.27 USD and the consensus revenue estimate is 839.38M USD.
The number of analysts covering ACADIA HEALTHCARE CO INC (ACHC) is 20.